Wakabayashi Yasushi, Mitsuhashi Takeshi, Fujita Hideo, Momomura Shin-Ichi
Division of Cardiovascular Medicine Saitama Medical Center Jichi Medical University Saitama Japan.
J Arrhythm. 2018 Dec 7;35(1):133-135. doi: 10.1002/joa3.12145. eCollection 2019 Feb.
A 62-year-old man with Brugada syndrome underwent subcutaneous implantable cardioverter defibrillator implantation. The lead was positioned along the left sternal border and defibrillation threshold (DFT) testing was performed. However, ventricular fibrillation (VF) was not terminated with 65 J and 80 J shocks. Shock impedance was 82 ohms. We repositioned the lead to the right sternal border and performed DFT testing again, followed by the VF termination with a 65 J shock. Shock impedance was 59 ohms. The positional relationship among the lead, generator, and heart was changed by lead repositioning, which may have contributed to improved shock impedance and DFT.
一名62岁的布加综合征男性患者接受了皮下植入式心律转复除颤器植入术。导线沿左胸骨旁放置,并进行了除颤阈值(DFT)测试。然而,65J和80J的电击未能终止室颤(VF)。电击阻抗为82欧姆。我们将导线重新放置到右胸骨旁并再次进行DFT测试,随后用65J的电击终止了室颤。电击阻抗为59欧姆。导线重新定位改变了导线、发生器和心脏之间的位置关系,这可能有助于改善电击阻抗和DFT。